These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26846177)

  • 1. Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer.
    Akahori T; Sho M; Tanaka T; Kinoshita S; Nagai M; Nishiwada S; Nishiofuku H; Ohbayashi C; Kichikawa K; Nakajima Y
    Am J Surg; 2016 Apr; 211(4):787-92. PubMed ID: 26846177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
    Matsumoto I; Tanaka M; Shirakawa S; Shinzeki M; Toyama H; Asari S; Goto T; Yamashita H; Ishida J; Ajiki T; Fukumoto T; Shimokawa M; Ku Y
    Ann Surg Oncol; 2015 Jul; 22(7):2408-15. PubMed ID: 25487967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type of Resection (Whipple vs. Distal) Does Not Affect the National Failure to Provide Post-resection Adjuvant Chemotherapy in Localized Pancreatic Cancer.
    Bergquist JR; Ivanics T; Shubert CR; Habermann EB; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB; Truty MJ
    Ann Surg Oncol; 2017 Jun; 24(6):1731-1738. PubMed ID: 28070725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy following resection for pancreatic adenocarcinoma.
    Brennan MF
    Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
    White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined-modality treatment for operable pancreatic adenocarcinoma.
    Pisters PW; Wolff RA; Crane CH; Evans DB
    Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.
    Merkow RP; Bilimoria KY; Tomlinson JS; Paruch JL; Fleming JB; Talamonti MS; Ko CY; Bentrem DJ
    Ann Surg; 2014 Aug; 260(2):372-7. PubMed ID: 24374509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
    J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: challenging the boundaries.
    Khan AZ; Pitsinis V; Mudan SS
    World J Gastroenterol; 2007 Dec; 13(47):6433-5. PubMed ID: 18081235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of resected pancreatic cancer without adjuvant chemotherapy.
    Hernandez JM; Morton CA; Al-Saadi S; Villadolid D; Cooper J; Bowers C; Rosemurgy AS
    Am Surg; 2010 May; 76(5):480-5. PubMed ID: 20506876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancer.
    Klein F; Bahra M; Schirmeier A; Al-Abadi H; Pratschke J; Pelzer U; Oettle H; Striefler J; Riess H; Sinn M
    J Surg Oncol; 2015 Jul; 112(1):66-71. PubMed ID: 26193339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiotherapy for pancreatic cancer: current status and perspectives.
    Oya N
    Int J Clin Oncol; 2004 Dec; 9(6):451-7. PubMed ID: 15616875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.
    Meszoely IM; Wang H; Hoffman JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):685-96, x. PubMed ID: 15350942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma.
    Artinyan A; Anaya DA; McKenzie S; Ellenhorn JD; Kim J
    Cancer; 2011 May; 117(10):2044-9. PubMed ID: 21523715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.